Local Health Unit 10, Florence, Italy
Data from Italy, the United States and Netherlands advance knowledge in heart attack research
Published in Pharma Law Weekly, September 12th, 2006
Study 1: Increased mortality in patients with chronic comorbidity and STEMI derives, at least in part, from underutilization of coronary reperfusion therapy.
Researchers working in Italy report, "Chronic comorbidity is a prognostic determinant in ST-segment elevation myocardial infarction (STEMI). This study was aimed at determining to what extent this effect is independent or derives from adoption of different therapeutic strategies."
"Seven hundred forty patients with STEMI hospitalized within 12 hours of symptom onset were enrolled...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-09-12)
More Articles from Pharma Law Weekly
- Ariad Pharmaceuticals
Ariad gets patent covering mTOR inhibitors, treatment methods in cancer and restenosis - Arrowhead Research
Arrowhead announces issuance of patent on subsidiary's key technology - Columbia University, U.S.
Recent findings in colon cancer described by researchers from the United States and Taiwan - Costa Brava
Costa Brava Partnership III L.P. files suit against Bradley Pharmaceuticals, Inc. - EntreMed
EntreMed receives composition-of-matter patent for 2ME2 - Food and Drug Administration, U.S.
U.S. FDA warns three pharmacies to stop mass-producing unapproved inhalation drugs - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
